Bruker Corporation
BRKR
$57.71
$0.040.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 838.50M | 823.40M | 977.20M | 860.50M | 797.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 838.50M | 823.40M | 977.20M | 860.50M | 797.40M |
| Cost of Revenue | 421.40M | 428.20M | 510.40M | 446.30M | 432.30M |
| Gross Profit | 417.10M | 395.20M | 466.80M | 414.20M | 365.10M |
| SG&A Expenses | 238.90M | 242.20M | 244.20M | 242.50M | 231.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.10M | 800.00K | 58.70M | -38.10M | 3.50M |
| Total Operating Expenses | 755.70M | 772.50M | 912.90M | 749.00M | 767.40M |
| Operating Income | 82.80M | 50.90M | 64.30M | 111.50M | 30.00M |
| Income Before Tax | -36.70M | 18.20M | 67.00M | -72.60M | 1.10M |
| Income Tax Expenses | 14.20M | 2.50M | 37.80M | -14.10M | -3.10M |
| Earnings from Continuing Operations | -50.90M | 15.70M | 29.20M | -58.50M | 4.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.10M | -1.30M | -3.20M | -1.10M | 3.40M |
| Net Income | -52.00M | 14.40M | 26.00M | -59.60M | 7.60M |
| EBIT | 82.80M | 50.90M | 64.30M | 111.50M | 30.00M |
| EBITDA | 140.80M | 109.20M | 122.40M | 167.20M | 86.10M |
| EPS Basic | -0.41 | 0.02 | 0.10 | -0.41 | 0.05 |
| Normalized Basic EPS | 0.35 | 0.19 | 0.20 | 0.43 | 0.10 |
| EPS Diluted | -0.41 | 0.02 | 0.10 | -0.41 | 0.05 |
| Normalized Diluted EPS | 0.35 | 0.19 | 0.20 | 0.43 | 0.10 |
| Average Basic Shares Outstanding | 152.20M | 152.20M | 152.00M | 151.80M | 151.60M |
| Average Diluted Shares Outstanding | 152.30M | 152.70M | 152.50M | 151.80M | 151.70M |
| Dividend Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Payout Ratio | -35.58% | 129.17% | 67.69% | 0.00% | 100.00% |